{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:09:36Z","timestamp":1788260976148,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd004179","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,3,30]],"date-time":"2016-03-30T00:00:00Z","timestamp":1459296000000}}],"reference-count":96,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004179.pub2","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T03:19:42Z","timestamp":1459394382000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair"],"prefix":"10.1002","volume":"2016","author":[{"given":"Rachel","family":"Forster","sequence":"first","affiliation":[{"name":"University of Edinburgh; Usher Institute of Population Health Sciences and Informatics; Edinburgh UK EH8 9AG"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene","family":"Stewart","sequence":"additional","affiliation":[{"name":"University of Edinburgh; Usher Institute of Population Health Sciences and Informatics; Edinburgh UK EH8 9AG"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,3,30]]},"reference":[{"issue":"26","key":"10.1002\/14651858.CD004179.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa1006885","article-title":"Apixaban versus enoxaparin for thromboprophylaxis after hip replacement","volume":"363","author":"Lassen","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004179.pub2-BIB0002|cit2","unstructured":"NCT00423319 Study of an investigational drug for the prevention of thrombosis-related events following hip replacement surgery (ADVANCE-3) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00423319?term=NCT00423319&rank=1"},{"issue":"3","key":"10.1002\/14651858.CD004179.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/jth.12109","article-title":"Apixaban after hip or knee arthroplasty versus enoxaparin: Efficacy and safety in key clinical subgroups","volume":"11","author":"Pineo","year":"2013","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD004179.pub2-BIB0004|cit4","doi-asserted-by":"crossref","unstructured":"Raskob GE Gallus AS Pineo GF Chen D Ramirez LM Lassen MR Apixaban versus enoxaparin for thromboprophylaxis after joint replacement surgery: pooled analysis of major venous thromboembolism and bleeding in 8,464 patients from the advance 2 and 3 trials [Abstract No. 192] Blood 2010","DOI":"10.1182\/blood.V116.21.192.192"},{"issue":"2","key":"10.1002\/14651858.CD004179.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1302\/0301-620X.94B2.27850","article-title":"Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials","volume":"94","author":"Raskob","year":"2012","journal-title":"Journal of Bone and Joint Surgery. British Volume"},{"issue":"4","key":"10.1002\/14651858.CD004179.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1016\/j.thromres.2010.07.018","article-title":"Short versus extended thromboprophylaxis after total knee arthroplasty: a randomized comparison","volume":"126","author":"Barrellier","year":"2010","journal-title":"Thrombosis Research"},{"issue":"45","key":"10.1002\/14651858.CD004179.pub2-BIB0007|cit7","first-page":"197","article-title":"Dalteparin new treatment duration: new dosage. Is prolonged prophylaxis needed?","volume":"9","author":"Anon","year":"2000","journal-title":"Prescrire International"},{"issue":"5","key":"10.1002\/14651858.CD004179.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1046\/j.1538-7836.2003.00111.x","article-title":"Sustained prothrombotic profile after hip replacement surgery: the influence of prolonged prophylaxis with dalteparin","volume":"1","author":"Arnesen","year":"2003","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"1","key":"10.1002\/14651858.CD004179.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-0038-1655901","article-title":"Prolonged thromboprophylaxis following hip replacement surgery--results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin)","volume":"77","author":"Dahl","year":"1997","journal-title":"Thrombosis and Haemostasis"},{"issue":"6","key":"10.1002\/14651858.CD004179.pub2-BIB0010|cit10","first-page":"1094-Abstract N","article-title":"The effect of prolonged thromboprophylaxis with dalteparin on the frequency of deep vein thrombosis (DVT) and pulmonary embolism (PE) 35 days after hip replacement surgery (HRS)","volume":"73","author":"Dahl","year":"1995","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD004179.pub2-BIB0012|cit11","unstructured":"Lassen MR Borris LC Prolonged thromboprophylaxis with low molecular weight heparin (Fragmin) after elective total hip arthroplasty - a placebo controlled study Thrombosis and Haemostasis 1995 1104"},{"issue":"6","key":"10.1002\/14651858.CD004179.pub2-BIB0011|cit12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0049-3848(98)00018-8","article-title":"Efficacy and safety of prolonged thromboprophylaxis with a low molecular weight heparin (dalteparin) after total hip arthroplasty--the Danish Prolonged Prophylaxis (DaPP) Study","volume":"89","author":"Lassen","year":"1998","journal-title":"Thrombosis Research"},{"issue":"3","key":"10.1002\/14651858.CD004179.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.thromres.2008.02.017","article-title":"Safety assessment of new antithrombotic agents: Lessons from the EXTEND study on ximelagatran","volume":"123","author":"Agnelli","year":"2009","journal-title":"Thrombosis Research"},{"key":"10.1002\/14651858.CD004179.pub2-BIB0015|cit14","doi-asserted-by":"crossref","unstructured":"Hull RD New insights into extended prophylaxis after orthopaedic surgery - the North American Fragmin Trial experience Haemostasis 2000 95 100","DOI":"10.1159\/000054172"},{"issue":"14","key":"10.1002\/14651858.CD004179.pub2-BIB0014|cit15","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1001\/archinte.160.14.2208","article-title":"Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin\/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial Investigators","volume":"160","author":"Hull","year":"2000","journal-title":"Archives of Internal Medicine"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD004179.pub2-BIB0020|cit16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3928\/0147-7447-19970202-08","article-title":"The post-hospital discharge venous thrombosis risk of the orthopedic patient","volume":"20","author":"Planes","year":"1997","journal-title":"Orthopedics"},{"key":"10.1002\/14651858.CD004179.pub2-BIB0016|cit17","doi-asserted-by":"crossref","unstructured":"Planes A Vochelle N Compan D Weisslinger N Huet Y Efficacy and safety of prolonged administration of enoxaparin in the prevention of deep venous thrombosis after elective total hip replacement Orthopaedic Transactions 1996 274","DOI":"10.2165\/00003495-199600527-00009"},{"issue":"Suppl 7","key":"10.1002\/14651858.CD004179.pub2-BIB0017|cit18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00003495-199600527-00009","article-title":"Efficacy and safety of postdischarge administration of enoxaparin in the prevention of deep venous thrombosis after total hip replacement. A prospective randomised double-blind placebo-controlled trial","volume":"52","author":"Planes","year":"1996","journal-title":"Drugs"},{"issue":"9022","key":"10.1002\/14651858.CD004179.pub2-BIB0018|cit19","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0140-6736(96)01453-5","article-title":"Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo","volume":"348","author":"Planes","year":"1996","journal-title":"Lancet"},{"issue":"2 Suppl Evidenc","key":"10.1002\/14651858.CD004179.pub2-BIB0019|cit20","doi-asserted-by":"crossref","first-page":"125S","DOI":"10.1378\/chest.114.2_Supplement.125S","article-title":"Out-of-hospital prophylaxis with low-molecular-weight heparin in hip surgery: the French study--venographic outcome at 35 days","volume":"114","author":"Planes","year":"1998","journal-title":"Chest"},{"key":"10.1002\/14651858.CD004179.pub2-BIB0021|cit21","first-page":"500a","article-title":"Extended out-of-hospital LMWH venous thromboembolism prophylaxis after total hip or knee replacement surgery","volume":"92","author":"Heit","year":"1998","journal-title":"Blood"},{"issue":"11","key":"10.1002\/14651858.CD004179.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"853","DOI":"10.7326\/0003-4819-132-11-200006060-00002","article-title":"Ardeparin sodium for extended out-of-hospital prophylaxis against venous thromboembolism after total hip or knee replacement. A randomized, double-blind, placebo-controlled trial","volume":"132","author":"Heit","year":"2000","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD004179.pub2-BIB0023|cit23","unstructured":"Kolb G Bodamer I Galster H Grambach K Koudela K Eisele RR Prolonged prophylaxis with the low molecular weight heparin certoparin reduces the rate of venous thromboembolism after orthopedic surgery Journal of Thrombosis and Haemostasis 2003 Abstract: P1868"},{"issue":"6","key":"10.1002\/14651858.CD004179.pub2-BIB0024|cit24","first-page":"1100","article-title":"Reduction of venous thromboembolism following prolonged prophylaxis with the low molecular weight heparin Certoparin after endoprothetic joint replacement or osteosynthesis of the lower limb in elderly patients","volume":"90","author":"Kolb","year":"2003","journal-title":"Thrombosis and Haemostasis"},{"issue":"17","key":"10.1002\/14651858.CD004179.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1001\/archinte.162.17.1966","article-title":"Prolonged thromboprophylaxis with oral anticoagulants after total hip arthroplasty: a prospective controlled randomized study","volume":"162","author":"Prandoni","year":"2002","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD004179.pub2-BIB0026|cit26","unstructured":"Anon Prevention of thromboembolism after knee replacement surgery: rivaroxaban one tablet\/once daily superior to twice daily injectable enoxaparin in preventing venous blood clots after total knee replacement surgery in pivotal phase III trial http:\/\/www.bayer.ca\/ 2008"},{"issue":"2","key":"10.1002\/14651858.CD004179.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1160\/TH11-07-0447","article-title":"Stress-induced hyperglycaemia and venous thromboembolism following total hip or total knee arthroplasty. Analysis from the RECORD trials","volume":"107","author":"Cohn","year":"2012","journal-title":"Thrombosis and Haemostasis"},{"issue":"11","key":"10.1002\/14651858.CD004179.pub2-BIB0028|cit28","first-page":"6","article-title":"Oral rivaroxaban compared with subcutaneous enoxaparin for extended thromboprophylaxis after total hip arthroplasty: The RECORD1 trial","volume":"110","author":"Eriksson","year":"2007","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004179.pub2-BIB0029|cit29","first-page":"82","article-title":"Oral rivaroxaban versus subcutaneous enoxaparin for extended thromboprophylaxis after total hip replacement: RECORD1 (abstract 222)","volume":"141","author":"Eriksson","year":"2008","journal-title":"British Journal of Haematology"},{"issue":"26","key":"10.1002\/14651858.CD004179.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1056\/NEJMoa0800374","article-title":"Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty","volume":"358","author":"Eriksson","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD004179.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1302\/0301-620X.91B5.21691","article-title":"Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement","volume":"91","author":"Eriksson","year":"2009","journal-title":"Journal of Bone and Joint Surgery. British Volume"},{"key":"10.1002\/14651858.CD004179.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.thromres.2011.12.005","article-title":"Concomitant use of medication with antiplatelet effects in patients receiving either rivaroxaban or enoxaparin after total hip or knee arthroplasty","volume":"130","author":"Eriksson","year":"2012","journal-title":"Thrombosis Research"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004179.pub2-BIB0033|cit33","first-page":"A15","article-title":"Rivaroxaban, an oral, direct factor Xa inhibitor in extended prophylaxis of thromboembolism after total hip replacement: RECORD1 (abstract O58)","volume":"36","author":"Haas","year":"2008","journal-title":"Pathophysiology of Haemostasis and Thrombosis"},{"issue":"11","key":"10.1002\/14651858.CD004179.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1302\/0301-620X.94B11.28955","article-title":"The effects of rivaroxaban on the complications of surgery after total hip or knee replacement: Results from the RECORD programme","volume":"94","author":"Lassen","year":"2012","journal-title":"Journal of Bone and Joint Surgery. British Volume"},{"key":"10.1002\/14651858.CD004179.pub2-BIB0035|cit35","unstructured":"NCT00329628 Rivaroxaban (10mg) given once daily in patients undergoing total hip replacement compared to enoxaparin https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00329628?term=NCT00329628&rank=1"},{"issue":"5","key":"10.1002\/14651858.CD004179.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/aas.12069","article-title":"Incidence of neuraxial haematoma after total hip or knee surgery: RECORD programme (rivaroxaban vs. enoxaparin)","volume":"57","author":"Rosencher","year":"2013","journal-title":"Acta Anaesthesiologica Scandinavica"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004179.pub2-BIB0037|cit37","first-page":"A15","article-title":"A phase III study of extended thromboprophylaxis with oral rivaroxaban versus short-term subcutaneous enoxaparin after total hip replacement: RECORD2 (abstract O59)","volume":"36","author":"Kakkar","year":"2008","journal-title":"Pathophysiology of Haemostasis and Thrombosis"},{"issue":"9632","key":"10.1002\/14651858.CD004179.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)60880-6","article-title":"Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial","volume":"372","author":"Kakkar","year":"2008","journal-title":"Lancet"},{"issue":"11","key":"10.1002\/14651858.CD004179.pub2-BIB0039|cit39","first-page":"307","article-title":"Extended thromboprophylaxis with rivaroxaban compared with short-term thromboprophylaxis with enoxaparin after total hip arthroplasty: The RECORD2 trial","volume":"110","author":"Kakkar","year":"2007","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004179.pub2-BIB0040|cit40","first-page":"65","article-title":"RECORD2: extended thromboprophylaxis with rivaroxaban versus short-term thromboprophylaxis with enoxaparin after total hip replacement (abstract 176)","volume":"141","author":"Kakkar","year":"2008","journal-title":"British Journal of Haematology"},{"issue":"3","key":"10.1002\/14651858.CD004179.pub2-BIB0041|cit41","first-page":"15","article-title":"Extended thrombosis prophylaxis with rivaroxaban in comparison to short-term thrombosis prophylaxis with enoxaparin after total hip replacement: The RECORD2 study","volume":"103","author":"Mouret","year":"2008","journal-title":"Medizinische Klinik"},{"key":"10.1002\/14651858.CD004179.pub2-BIB0042|cit42","unstructured":"NCT00332020 Regulation of coagulation in orthopedic surgery to prevent DVT and PE, a controlled, double-blind, randomized study of BAY 59-7939 in the extended prevention of VTE in patients undergoing elective total hip replacement (RECORD 2) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00332020?term=NCT00332020&rank=1"},{"issue":"4","key":"10.1002\/14651858.CD004179.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1160\/TH10-10-0679","article-title":"Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II): A randomised, double-blind, non-inferiority trial","volume":"105","author":"Eriksson","year":"2011","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD004179.pub2-BIB0044|cit44","unstructured":"Huo M Eriksson B Dahl O Kurth A Hantel S Hermasson K Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty: the RE-NOVATE II randomised trial [Abstract No. 0564] Haematologica 2010 233"},{"key":"10.1002\/14651858.CD004179.pub2-BIB0045|cit45","unstructured":"NCT00657150 Dabigatran etexilate compared with enoxaparin in prevention of venous thromboembolism (VTE) following total hip arthroplasty https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00657150?term=RE-NOVATE&rank=1"},{"issue":"9591","key":"10.1002\/14651858.CD004179.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(07)61445-7","article-title":"Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial","volume":"370","author":"Eriksson","year":"2007","journal-title":"Lancet"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD004179.pub2-BIB0047|cit47","first-page":"OW","article-title":"Dabigatran etexilate is effective and safe for the extended prevention of venous thromboembolism following total hip replacement (abstract OW-049)","volume":"5","author":"Eriksson","year":"2007","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD004179.pub2-BIB0048|cit48","unstructured":"NCT00168818 Dabigatran etexilate in extended VTE prevention after hip replacement surgery https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00168818?term=RE-NOVATE&rank=2"},{"issue":"19","key":"10.1002\/14651858.CD004179.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/archinte.162.19.2191","article-title":"Extended venous thromboembolism prophylaxis after total hip replacement: a comparison of low-molecular-weight heparin with oral anticoagulant","volume":"162","author":"Samama","year":"2002","journal-title":"Archives of Internal Medicine"},{"issue":"7","key":"10.1002\/14651858.CD004179.pub2-BIB0050|cit50","first-page":"525","article-title":"Effects of thromboprophylaxis duration on coagulation indicators after total hip replacement","volume":"94","author":"Zhang","year":"2014","journal-title":"National Medical Journal of China"},{"issue":"3","key":"10.1002\/14651858.CD004179.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"336","DOI":"10.2106\/00004623-200103000-00004","article-title":"Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. Enoxaparin Clinical Trial Group","volume":"83-A","author":"Comp","year":"2001","journal-title":"Journal of Bone & Joint Surgery - American Volume"},{"key":"10.1002\/14651858.CD004179.pub2-BIB0052|cit52","doi-asserted-by":"crossref","unstructured":"Spiro TE A double-blind multicenter clinical trial comparing long term enoxaparin and placebo treatments in the prevention of venous thromboembolic disease after hip and knee replacement surgery Blood 1997 295a","DOI":"10.1016\/S0883-5403(98)90123-1"},{"key":"10.1002\/14651858.CD004179.pub2-BIB0053|cit53","unstructured":"NCT01720108 Extended venous thromboembolism prophylaxis comparing rivaroxaban to aspirin following total hip and knee arthroplasty (EPCAT II) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01720108"},{"key":"10.1002\/14651858.CD004179.pub2-BIB0054|cit54","first-page":"447","article-title":"Combined treatment with indomethacin and low-dose heparin after total hip replacement","volume":"72","author":"Kristensen","year":"1990","journal-title":"Journal of Bone and Joint Surgery. American Volume"},{"issue":"5","key":"10.1002\/14651858.CD004179.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000029297","article-title":"Prolonged prophylaxis with unfractioned heparin is effective to reduce delayed deep vein thrombosis in total hip replacement","volume":"65","author":"Manganelli","year":"1998","journal-title":"Respiration"},{"key":"10.1002\/14651858.CD004179.pub2-BIB0056|cit56","doi-asserted-by":"crossref","unstructured":"Palla A Manganelli D Rossi G Prolonged prophylaxis with unfractioned heparin (UH) is effective to reduce delayed deep vein thrombosis (DVT) in total hip replacement (THR) European Respiratory Journal 1997 5S","DOI":"10.1159\/000029297"},{"issue":"1","key":"10.1002\/14651858.CD004179.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/112070000101100103","article-title":"Prevention of venous thromboembolism after hospital discharge. Continued pharmacologic prophylaxis versus no prophylaxis in patients undergoing total hip replacement","volume":"11","author":"Haentjens","year":"2001","journal-title":"Hip International"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004179.pub2-BIB0058|cit58","first-page":"78","article-title":"Post-hospital discharge prevention of deep vein thrombosis with nadroparin calcium after elective total hip replacement","volume":"82","author":"Haentjens","year":"1999","journal-title":"British Journal of Anaesthesia"},{"key":"10.1002\/14651858.CD004179.pub2-BIB0059|cit59","unstructured":"The Belgian Nadroparin Post Hospital Discharge in Orthopedics (NPHDO) Study Group Post hospital discharge prevention of deep vein thrombosis with nadroparin calcium after total hip arthroplasty Haemostasis 1998 292"},{"key":"10.1002\/14651858.CD004179.pub2-BIB0060|cit60","unstructured":"Anon A multicenter, multinational, randomized, double-blind study of fondaparinux sodium (Org31540\/SR90107A) versus placebo for the prolonged prevention of VTE in hip fracture surgery. (PENTIHFRA PLUS). Study No: EFC4582 GlaxoSmithKline Clinical Trial Register 2005"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004179.pub2-BIB0061|cit61","first-page":"P2050","article-title":"No episode of thrombocytopenia after four-week administration of fondaparinux, a new synthetic and selective inhibitor of factor Xa, in the PENTHIFRA-PLUS study","volume":"1","author":"Bauer","year":"2003","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"22 Suppl 7","key":"10.1002\/14651858.CD004179.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1093\/ajhp\/60.suppl_7.S15","article-title":"Novel concepts: emerging data and the role of extended prophylaxis following hip fracture surgery","volume":"60","author":"Dobesh","year":"2003","journal-title":"American Journal of Health-System Pharmacy"},{"key":"10.1002\/14651858.CD004179.pub2-BIB0066|cit63","unstructured":"Eriksson BI A multicenter, randomized, placebo-controlled, double-blind study of fondaparinux for the prolonged prevention of venous thromboembolism in hip fracture surgery Abstracts of the Sicot\/Sirot XXII World Congress 2002 318"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004179.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"Abstract P2064","DOI":"10.1111\/j.1538-7836.2003.tb05548.x","article-title":"Consistency of efficacy of extended thromboprophylaxis with fondaparinux (arixtra) in prevention of venous thromboembolism (VTE) after hip fracture surgery according to different composite efficacy endpoints: the PENTHIFRA-PLUS study","volume":"1","author":"Eriksson","year":"2003","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"11","key":"10.1002\/14651858.CD004179.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1001\/archinte.163.11.1337","article-title":"Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: A multicenter, randomized, placebo-controlled, double-blind study","volume":"163","author":"Eriksson","journal-title":"Archives of Internal Medicine"},{"issue":"7 Suppl 2","key":"10.1002\/14651858.CD004179.pub2-BIB0063|cit66","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.arth.2004.06.012","article-title":"Efficacy of fondaparinux for thromboprophylaxis in hip fracture patients","volume":"19","author":"Eriksson","year":"2004","journal-title":"Journal of Arthroplasty"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004179.pub2-BIB0067|cit67","first-page":"Abstract number","article-title":"Absence of transaminase increase after 4-week administration of fondaparinux (Arixtra\u00ae) a new synthetic and selective inhibitor of factor Xa in the PENTHIFRA-PLUS study","volume":"1","author":"Lassen","year":"2003","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"10","key":"10.1002\/14651858.CD004179.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1056\/NEJM199609053351002","article-title":"Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement","volume":"335","author":"Bergqvist","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004179.pub2-BIB0069|cit69","first-page":"130","article-title":"Cost-effectiveness of prolonged out-of-hospital prophylaxis with low-molecular-weight heparin following total hip replacement","volume":"30 Suppl 2","author":"Bergqvist","year":"2000","journal-title":"Haemostasis"},{"key":"10.1002\/14651858.CD004179.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3928\/0147-7447-19970202-09","article-title":"The post-discharge prophylactic management of the orthopedic patient with low-molecular-weight heparin: enoxaparin","volume":"20 Suppl","author":"Nilsson","year":"1997","journal-title":"Orthopedics"},{"issue":"7454","key":"10.1002\/14651858.CD004179.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD004179.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1053\/j.seminhematol.2007.02.004","article-title":"Epidemiology and risk factors for venous thrombosis","volume":"44","author":"Cushman","year":"2007","journal-title":"Seminars in Hematology"},{"key":"10.1002\/14651858.CD004179.pub2-BIB0073|cit73","unstructured":"Dotzel MM Determination that ardeparin sodium injection was not withdrawn from sale for reasons of safety or effectiveness US Food and Drug Administration 2002 http:\/\/www.fda.gov\/ohrms\/dockets\/98fr\/052302b.htm (date accessed September 2015)"},{"issue":"7109","key":"10.1002\/14651858.CD004179.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"9275","key":"10.1002\/14651858.CD004179.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(00)05249-1","article-title":"Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials","volume":"358","author":"Eikelboom","year":"2001","journal-title":"Lancet"},{"issue":"19","key":"10.1002\/14651858.CD004179.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJM199711063371901","article-title":"A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement [see comments]","volume":"337","author":"Eriksson","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004179.pub2-BIB0077|cit77","unstructured":"McMaster University (developed by Evidence Prime, Inc). Available from www.gradepro.org GRADEpro Guideline Development Tool (GRADEpro GDT) 2015"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD004179.pub2-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"7S","DOI":"10.1378\/chest.1412S3","article-title":"Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Guyatt","year":"2012","journal-title":"Chest"},{"key":"10.1002\/14651858.CD004179.pub2-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"464\u201374","DOI":"10.1038\/nrcardio.2015.83","article-title":"Epidemiology of venous thromboembolism","volume":"12","author":"Heit","year":"2015","journal-title":"Nature Reviews Cardiology"},{"issue":"7414","key":"10.1002\/14651858.CD004179.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004179.pub2-BIB0081|cit81","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"2 Suppl Evidenc","key":"10.1002\/14651858.CD004179.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"113S","DOI":"10.1378\/chest.114.2_Supplement.113S","article-title":"Evidence for the needs of out-of-hospital thrombosis prophylaxis: introduction","volume":"114","author":"Hirsh","year":"1998","journal-title":"Chest"},{"issue":"9096","key":"10.1002\/14651858.CD004179.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(97)08468-7","article-title":"Summing up evidence: one answer is not always enough","volume":"351","author":"Lau","year":"1998","journal-title":"Lancet"},{"issue":"2 Suppl II","key":"10.1002\/14651858.CD004179.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"115S","DOI":"10.1378\/chest.114.2_Supplement.115S","article-title":"The incidence of symptomatic venous thromboembolism after enoxaparin prophylaxis in lower extremity arthroplasty: a cohort study of 1,984 patients","volume":"114","author":"Leclerc","year":"1998","journal-title":"Chest"},{"issue":"1","key":"10.1002\/14651858.CD004179.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/jth.12440","article-title":"Extended-duration new oral anticoagulants for venous thromboprophylaxis in patients undergoing total hip arthroplasty: A meta-analysis of the randomized controlled trials","volume":"12","author":"Liew","year":"2014","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"19","key":"10.1002\/14651858.CD004179.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1001\/archinte.1993.00410190057007","article-title":"Prophylactic agents for venous thrombosis in elective hip surgery: Meta-analysis of studies using venographic assessment","volume":"153","author":"Mohr","year":"1993","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD004179.pub2-BIB0087|cit87","unstructured":"National Clinical Guideline Centre Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. Methods evidence and guidance http:\/\/www.nice.org.uk\/guidance\/cg92\/evidence\/cg92-venous-thromboembolism-reducing-the-risk-full-guideline3 (accessed September 2015)"},{"key":"10.1002\/14651858.CD004179.pub2-BIB0088|cit88","unstructured":"National Clinical Guideline Centre Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing. Clinical Guideline. Methods, evidence and recommendations http:\/\/www.nice.org.uk\/guidance\/cg144\/evidence\/cg144-venous-thromboembolic-diseases-full-guideline3 (accessed September 2015)"},{"issue":"8812","key":"10.1002\/14651858.CD004179.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0140-6736(92)93223-A","article-title":"Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis","volume":"340","author":"Nurmohamed","year":"1992","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004179.pub2-BIB0090|cit90","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"6","key":"10.1002\/14651858.CD004179.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"439","DOI":"10.7326\/0003-4819-127-6-199709150-00004","article-title":"Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty: the post-arthroplasty screening study. A randomized, controlled trial","volume":"127","author":"Robinson","year":"1997","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD004179.pub2-BIB0092|cit92","unstructured":"Scottish Intercollegiate Guidelines Network Thrombosis Guidelines Prevention and management of venous thromboembolism. A national clinical guideline http:\/\/www.sign.ac.uk\/pdf\/sign122.pdf (accessed September 2015)"},{"issue":"6965","key":"10.1002\/14651858.CD004179.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1136\/bmj.309.6965.1351","article-title":"Why sources of heterogeneity in meta-analysis should be investigated","volume":"309","author":"Thompson","year":"1994","journal-title":"BMJ (Clinical research ed.)"},{"issue":"4","key":"10.1002\/14651858.CD004179.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"e91755","DOI":"10.1371\/journal.pone.0091755","article-title":"Surgical site infections and other postoperative complications following prophylactic anticoagulation in total joint arthroplasty","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1002\/14651858.CD004179.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"I","DOI":"10.1161\/01.CIR.0000078468.11849.66","article-title":"The epidemiology of venous thromboembolism","volume":"107","author":"White","year":"2003","journal-title":"Circulation"},{"issue":"2","key":"10.1002\/14651858.CD004179.pub2-BIB0096|cit96","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004179","article-title":"Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair","author":"Quinlan","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD004179.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T09:55:19Z","timestamp":1713866119000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004179.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Vascular Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,3,30]]},"references-count":96,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004179.pub2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726254038.793568798","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,30]]}}}